https://orcid.org/0000-0001-5942-0550
Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Daniel A Kinderlehrer. (2023) The Effectiveness of Microdosed Psilocybin in the Treatment of Neuropsychiatric Lyme Disease: A Case Study. International Medical Case Reports Journal 16, pages 109-115.
Read now
Read now
F Schifano, A Vento, N Scherbaum & A Guirguis. (2023) Stimulant and hallucinogenic novel psychoactive substances; an update. Expert Review of Clinical Pharmacology 16:11, pages 1109-1123.
Read now
Read now
Erin Kasson, Lindsey M. Filiatreau, Kevin Davet, Nina Kaiser, Georgi Sirko, Mehaly Bekele & Patricia Cavazos-Rehg. (2023) Examining Symptoms of Stimulant Misuse and Community Support Among Members of a Recovery-Oriented Online Community. Journal of Psychoactive Drugs 0:0, pages 1-11.
Read now
Read now
Lindsay Shaw, Kerri Rea, Nathan J. Lachowsky & Eric Abella Roth. (2023) Magic Mushroom Use: A Qualitative Interview Study of Post-Trip Impacts and Strategies for Optimizing Experiences. Journal of Psychoactive Drugs 55:2, pages 151-158.
Read now
Read now
Joel Bornemann. (2020) The Viability of Microdosing Psychedelics as a Strategy to Enhance Cognition and Well-being - An Early Review. Journal of Psychoactive Drugs 52:4, pages 300-308.
Read now
Read now
Alyssa F. Harlow, Peter S. Hendricks, Adam M. Leventhal & Jessica L. Barrington-Trimis. Psychedelic Microdosing among Young Adults from Southern California. Journal of Psychoactive Drugs 0:0, pages 1-12.
Read now
Read now
Estelle Miller, Vida Bojovic, Olivia Maddren, Prashant Rao, Dami Adesina, Anastasia Petrenko & Rhys Ponton. Psychedelic Drug Microdosing Practices: A Qualitative Online Exploration. Journal of Psychoactive Drugs 0:0, pages 1-10.
Read now
Read now
Articles from other publishers (50)
Sachin R Pendse, Neha Kumar & Munmun De Choudhury. (2024) Quantifying the Pollan Effect: Investigating the Impact of Emerging Psychiatric Interventions on Online Mental Health Discourse. Quantifying the Pollan Effect: Investigating the Impact of Emerging Psychiatric Interventions on Online Mental Health Discourse.
Ioana Pop & Jannis Dinkelacker. (2023) Unlocking the self: Can microdosing psychedelics make one feel more authentic?. Nordic Studies on Alcohol and Drugs 41:2, pages 142-155.
Crossref
Crossref
Ioana Andreea Pop, Erwin Gielens, Hannah Kottmann & Peter Achterberg. (2024) Exploring the discourses around microdosing psychedelics within the r/microdosing online community. Social Science & Medicine 347, pages 116702.
Crossref
Crossref
Rita Anne McNamara. (2024) Cultural Evolution of Religion, Spirituality and Ritual: Impacts On Human CooperationDie kulturelle Evolution von Religion, Spiritualität und Ritualen: Ihre Bedeutung für menschliche Kooperation. KZfSS Kölner Zeitschrift für Soziologie und Sozialpsychologie.
Crossref
Crossref
Eline C. H. M. Haijen, Petra P.M. Hurks & Kim P.C. Kuypers. (2024) Effects of Psychedelic Microdosing versus Conventional ADHD Medication Use on Emotion Regulation, Empathy, and ADHD Symptoms in Adults with severe ADHD symptoms: A Naturalistic Prospective Comparison Study. European Psychiatry, pages 1-43.
Crossref
Crossref
Alesha Wells, A. P. Suresh Muthukumaraswamy, Eva Morunga, Will Evans, Alana Cavadino, Mahima Bansal, Nicola J. Lawrence, Amanda Ashley, Nicholas R. Hoeh, Frederick Sundram, Allison J. Applebaum, Hineatua Parkinson & Lisa Reynolds. (2024) PAM trial protocol: a randomised feasibility study of psychedelic microdosing–assisted meaning-centred psychotherapy in advanced stage cancer patients. Pilot and Feasibility Studies 10:1.
Crossref
Crossref
Gregory Yates & Emily Melon. (2024) Trip-killers: a concerning practice associated with psychedelic drug use. Emergency Medicine Journal 41:2, pages 112-113.
Crossref
Crossref
Ava Wexler, Alexandra Dubinskaya, Julie Suyama, Barry R Komisaruk, Jennifer Anger & Karyn Eilber. (2024) Does MDMA have treatment potential in sexual dysfunction? A systematic review of outcomes across the female and male sexual response cycles. Sexual Medicine Reviews 12:1, pages 26-34.
Crossref
Crossref
James J. Gattuso, Carey Wilson, Anthony J. Hannan & Thibault Renoir. (2023) Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic review. Journal of Neurochemistry.
Crossref
Crossref
Yu Chi & Huai-yu Chen. (2023) Investigating Substance Use via Reddit: Systematic Scoping Review. Journal of Medical Internet Research 25, pages e48905.
Crossref
Crossref
Laura Andrea Pérez Duque. (2023) Investigación sobre microdosificación con hongos psilocibios: un artículo de reflexión. Cultura y Droga 28:35, pages 50-69.
Crossref
Crossref
Eline C. H. M. Haijen, Petra P. M. Hurks & Kim P. C. Kuypers. (2023) Trait mindfulness and personality characteristics in a microdosing ADHD sample: a naturalistic prospective survey study. Frontiers in Psychiatry 14.
Crossref
Crossref
David T. Kryszajtys, Jacqueline L. Bender, Brian Rush & Carol J. Strike. (2023) Decision-Making around Psychedelics for Depression and Anxiety: a Model Based on Online Discussions. International Journal of Mental Health and Addiction.
Crossref
Crossref
Sangmi Kim, Elise Warren, Tasfia Jahangir, Mohammed Al-Garadi, Yuting Guo, Yuan-Chi Yang, Sahithi Lakamana & Abeed Sarker. (2023) Characteristics of Intimate Partner Violence and Survivor’s Needs During the COVID-19 Pandemic: Insights From Subreddits Related to Intimate Partner Violence. Journal of Interpersonal Violence 38:17-18, pages 9693-9716.
Crossref
Crossref
Michael Tagen, Daniel Mantuani, Liron van Heerden, Alex Holstein, Linda E. Klumpers & Richard Knowles. (2023) The risk of chronic psychedelic and MDMA microdosing for valvular heart disease. Journal of Psychopharmacology 37:9, pages 876-890.
Crossref
Crossref
Robin J. Murphy, Rachael Sumner, William Evans, Rhys Ponton, Sanya Ram, Kate Godfrey, Anna Forsyth, Alana Cavadino, Venkat Krishnamurthy Naga, Todd Smith, Nicholas R. Hoeh, David B. Menkes & Suresh Muthukumaraswamy. (2023) Acute Mood-Elevating Properties of Microdosed Lysergic Acid Diethylamide in Healthy Volunteers: A Home-Administered Randomized Controlled Trial. Biological Psychiatry 94:6, pages 511-521.
Crossref
Crossref
Justin N Bonnieux, Baeleigh VanderZwaag, Zahra Premji, Albert Garcia-Romeu & Mauricio A Garcia-Barrera. (2023) Psilocybin’s effects on cognition and creativity: A scoping review. Journal of Psychopharmacology 37:7, pages 635-648.
Crossref
Crossref
Ahsan Riaz, Iqra Zareef, Anam Munawar, Allah Rakha & Naveed A. Shad. 2023. Modeling and Simulation of Functional Nanomaterials for Forensic Investigation. Modeling and Simulation of Functional Nanomaterials for Forensic Investigation
204
222
.
Maria Bălăeț, William Trender, Peter J. Hellyer & Adam Hampshire. (2023) Associations between the use of psychedelics and other recreational drugs with mental health and resilience during the COVID-19 pandemic. Frontiers in Psychiatry 14.
Crossref
Crossref
Anita Morrissette & Matthew Morrissette. (2022) “The Feeling of Failure Is Immense”: A Qualitative Analysis of the Experiences of Unmatched Residency Applicants Using Reddit. Academic Medicine 98:5, pages 623-628.
Crossref
Crossref
Edward M. Sellers & Myroslava K. Romach. (2023) Psychedelics: Science sabotaged by Social Media. Neuropharmacology 227, pages 109426.
Crossref
Crossref
Rebecca S. Ryan, Alex Copello & Andrew P. Fox. (2023) Experiences of microdosing psychedelics in an attempt to support wellbeing and mental health. BMC Psychiatry 23:1.
Crossref
Crossref
Ceyda Sayalı & Frederick S. Barrett. (2023) The costs and benefits of psychedelics on cognition and mood. Neuron 111:5, pages 614-630.
Crossref
Crossref
Ido Hartogsohn & Rotem Petranker. (2022) Set and setting in microdosing: an oft-overlooked principle. Psychopharmacology 239:12, pages 3771-3777.
Crossref
Crossref
Anna U. Odland, Jesper L. Kristensen & Jesper T. Andreasen. (2022) Animal Behavior in Psychedelic Research. Pharmacological Reviews 74:4, pages 1176-1205.
Crossref
Crossref
Isis M. Ornelas, Felipe A. Cini, Isabel Wießner, Encarni Marcos, Dráulio B. Araújo, Livia Goto-Silva, Juliana Nascimento, Sergio R.B. Silva, Marcelo N. Costa, Marcelo Falchi, Rodolfo Olivieri, Fernanda Palhano-Fontes, Eduardo Sequerra, Daniel Martins-de-Souza, Amanda Feilding, César Rennó-Costa, Luis Fernando Tófoli, Stevens K. Rehen & Sidarta Ribeiro. (2022) Nootropic effects of LSD: Behavioral, molecular and computational evidence. Experimental Neurology 356, pages 114148.
Crossref
Crossref
Benjamin Plackett. (2022) Psychedelic microdosing hits a rough patch in clinical trials. Nature 609:7929, pages S96-S97.
Crossref
Crossref
Lukas A. Basedow & Sören Kuitunen‐Paul. (2022) Motives for the use of serotonergic psychedelics: A systematic review. Drug and Alcohol Review 41:6, pages 1391-1403.
Crossref
Crossref
Camila Sanz, Federico Cavanna, Stephanie Muller, Laura de la Fuente, Federico Zamberlan, Matías Palmucci, Lucie Janeckova, Martin Kuchar, Facundo Carrillo, Adolfo M. García, Carla Pallavicini & Enzo Tagliazucchi. (2022) Natural language signatures of psilocybin microdosing. Psychopharmacology 239:9, pages 2841-2852.
Crossref
Crossref
Vince Polito & Paul Liknaitzky. (2022) The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955–2021) and recommendations for the field. Neuroscience & Biobehavioral Reviews 139, pages 104706.
Crossref
Crossref
Joseph M. Rootman, Maggie Kiraga, Pamela Kryskow, Kalin Harvey, Paul Stamets, Eesmyal Santos-Brault, Kim P. C. Kuypers & Zach Walsh. (2022) Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls. Scientific Reports 12:1.
Crossref
Crossref
Nicole Amada & Jacob Shane. (2022) Self-Actualization and the Integration of Psychedelic Experience: The Mediating Role of Perceived Benefits to Narrative Self-Functioning. Journal of Humanistic Psychology, pages 002216782210996.
Crossref
Crossref
Katharina C. Dixon‐Ward & Stella W. Y. Chan. (2021) ‘Faking it’: Exploring adolescent perceptions of depression (in)authenticity and ‘attention seeking’. British Journal of Clinical Psychology 61:2, pages 177-196.
Crossref
Crossref
Daniel W.J. Anson. (2022) Personas of plagiarism: The construction of the ‘plagiarist’ in Australian university subreddits. Linguistics and Education 69, pages 101050.
Crossref
Crossref
Manon van den Berg, Igor Magaraggia, Rudy Schreiber, Todd M. Hillhouse & Joseph H. Porter. (2022) How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework. Psychopharmacology 239:6, pages 1853-1879.
Crossref
Crossref
David Wyndham Lawrence, Robin Carhart-Harris, Roland Griffiths & Christopher Timmermann. (2022) Phenomenology and content of the inhaled N, N-dimethyltryptamine (N, N-DMT) experience. Scientific Reports 12:1.
Crossref
Crossref
Rotem Petranker, Juensung Kim & Thomas Anderson. (2022) Microdosing as a Response to the Meaning Crisis: A Qualitative Analysis. Journal of Humanistic Psychology, pages 002216782210750.
Crossref
Crossref
Joseph M Peill, Katie E Trinci, Hannes Kettner, Lea J Mertens, Leor Roseman, Christopher Timmermann, Fernando E Rosas, Taylor Lyons & Robin L Carhart-Harris. (2022) Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience. Journal of Psychopharmacology 36:1, pages 31-45.
Crossref
Crossref
Robin J. Murphy, Rachael L. Sumner, William Evans, David Menkes, Ingo Lambrecht, Rhys Ponton, Frederick Sundram, Nicholas Hoeh, Sanya Ram, Lisa Reynolds & Suresh Muthukumaraswamy. (2021) MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers. Trials 22:1.
Crossref
Crossref
Joseph M. Rootman, Pamela Kryskow, Kalin Harvey, Paul Stamets, Eesmyal Santos-Brault, Kim P. C. Kuypers, Vince Polito, Francoise Bourzat & Zach Walsh. (2021) Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers. Scientific Reports 11:1.
Crossref
Crossref
Dimitrios Liokaftos. (2021) Sociological investigations of human enhancement drugs: The case of microdosing psychedelics. International Journal of Drug Policy 95, pages 103099.
Crossref
Crossref
Hannah M. Dressler, Stephen J. Bright & Vince Polito. (2021) Exploring the relationship between microdosing, personality and emotional insight: A prospective study. Journal of Psychedelic Studies 5:1, pages 9-16.
Crossref
Crossref
Kim P. C. Kuypers. 2021. Modern CNS Drug Discovery. Modern CNS Drug Discovery
257
274
.
Matthias E. Liechti & Friederike Holze. 2022. Disruptive Psychopharmacology. Disruptive Psychopharmacology
3
21
.
Simon Andrew Vann Jones & Allison O’Kelly. (2020) Psychedelics as a Treatment for Alzheimer’s Disease Dementia. Frontiers in Synaptic Neuroscience 12.
Crossref
Crossref
Marcus W. Meinhardt, Cansu Güngör, Ivan Skorodumov, Lea J. Mertens & Rainer Spanagel. (2020) Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse. Neuropsychopharmacology 45:8, pages 1316-1322.
Crossref
Crossref
Toby Lea, Nicole Amada, Henrik Jungaberle, Henrike Schecke, Norbert Scherbaum & Michael Klein. (2020) Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders. Psychopharmacology 237:5, pages 1521-1532.
Crossref
Crossref
Kim P.C. Kuypers. (2020) The therapeutic potential of microdosing psychedelics in depression. Therapeutic Advances in Psychopharmacology 10, pages 204512532095056.
Crossref
Crossref
Toby Lea, Nicole Amada, Henrik Jungaberle, Henrike Schecke & Michael Klein. (2020) Microdosing psychedelics: Motivations, subjective effects and harm reduction. International Journal of Drug Policy 75, pages 102600.
Crossref
Crossref
Greg Ferenstein. (2021) Psychological Antecedents to the Effects of Psychedelics on Workplace Productivity: Interview Evidence of a Naturalistic Setting. SSRN Electronic Journal.
Crossref
Crossref